Baker Biotech Capital (GP), LLC
SEC-identified person · CIK 1244389 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Tranzyme INC TZYM | Officer | filed 2012 - 2012 |
| Genomic Health INC GHDX | Director | filed 2006 - 2012 |
| Xoma Royalty Corp XOMAD | Officer | filed 2012 - 2012 |
| Pharmacyclics INC pcyc | Officer | filed 2011 - 2012 |
| Trimeris INC TRMS | Director | filed 2011 - 2012 |
| Seagen Inc. SGEN | Director | filed 2006 - 2012 |
| Adolor Corp adlr | Officer | filed 2010 - 2012 |
| Viropharma INC VPHM | Officer | filed 2006 - 2011 |
| Auxilium Pharmaceuticals INC AUXL | Officer | filed 2010 - 2011 |
| Heron Therapeutics, INC. /DE/ appa | Officer | filed 2009 - 2011 |
| Incyte Corp INCY | Director | filed 2007 - 2010 |
| Diadexus, Inc. vxgn | Officer | filed 2010 - 2010 |
| Biocryst Pharmaceuticals INC BCRX | Officer | filed 2007 - 2009 |
| Allos Therapeutics INC ALTH | Officer | filed 2006 - 2009 |
| Intrabiotics Pharmaceuticals INC /DE RDEA | Officer | filed 2006 - 2008 |
| Neurogen Corp NRGN | Director | filed 2008 - 2008 |
| Idera Pharmaceuticals, INC. IDRA | Officer | filed 2006 - 2008 |
| Synvista Therapeutics, Inc. SYI | Officer | filed 2007 - 2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.